THE ROLE OF HTA AGENCY IN DRUG REIMBURSEMENT DECISION-MAKING PROCESS IN POLAND (HTA IMPACT)

被引：2
|
作者：
Kolasa, K. [1 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74230-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A251 / A251
页数：1
相关论文
共 50 条
  • [21] THE ROLE OF PHARMACOECONOMICS IN DRUG REIMBURSEMENT DECISION-MAKING IN THE NETHERLANDS
    Franken, M.
    Koopmanschap, M.
    VALUE IN HEALTH, 2009, 12 (07) : A247 - A247
  • [22] THE IMPORTANCE OF THE OVERALL SURVIVAL ENDPOINT IN EU HTA DECISION-MAKING
    Bustamante, M. M. D.
    Oshinowo, B.
    Subbotina, E.
    McGahan, S.
    VALUE IN HEALTH, 2019, 22 : S99 - S99
  • [23] EXPERT ELICITATION TECHNIQUES: INFORMING APPLICATION IN HTA DECISION-MAKING
    Riley, D.
    Fox, A.
    Hirst, A.
    Marciniak, A.
    Heron, L.
    VALUE IN HEALTH, 2023, 26 (12) : S554 - S554
  • [24] Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations
    Yuba, Tania Yuka
    Dutilh Novaes, Hillegonda Maria
    de Soarez, Patricia Coelho
    HEALTH RESEARCH POLICY AND SYSTEMS, 2018, 16
  • [25] Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations
    Tania Yuka Yuba
    Hillegonda Maria Dutilh Novaes
    Patrícia Coelho de Soárez
    Health Research Policy and Systems, 16
  • [26] ANALYSIS OF STAKEHOLDERS INVOLVED IN HTA DECISION MAKING PROCESS IN THE UK
    Kalbasko, A.
    Andreykiv, M.
    Van Engen, A.
    Zorzi, O.
    VALUE IN HEALTH, 2012, 15 (07) : A278 - A278
  • [27] HISTORICAL AND FUTURE DRIVERS FOR HTA IN REIMBURSEMENT SYSTEMS IN MEXICO AND POLAND
    Kirpekar, S.
    Shankland, B.
    VALUE IN HEALTH, 2011, 14 (07) : A554 - A555
  • [28] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT AGENCIES (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    VALUE IN HEALTH, 2008, 11 (06) : A377 - A377
  • [29] BUILDING QUALITY IN HTA PROCESS AND DECISION MAKING: CAN KEY PERFORMANCE MEASURES OF GOOD PRACTICES IN HTA BE IDENTIFIED?
    Wang, T.
    VALUE IN HEALTH, 2015, 18 (03) : A96 - A96
  • [30] Most important barriers and facilitators of HTA usage in decision-making in Europe
    Cheung, K. L.
    Evers, S. M. A. A.
    De Vries, H.
    Levy, P.
    Pokhrel, S.
    Jones, T.
    Danner, M.
    Wentlandt, J.
    Knufinke, L.
    Mayer, S.
    Hiligsmann, M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (03) : 297 - 304
12345